New Drugs and Targets for Asthma & COPD
Imperial College London / National Heart & Lung Institute
Archivo
25.11.2009 - 27.11.2009 London
Contenido de curso
This popular annual course is focussed on the identification of novel targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area.
This popular annual course is focussed on the identification of novel targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area.
Destinatario
The course will be of particular relevance to those in the pharmaceutical industry, researchers in the field of respiratory medicine, and specialised clinicians and health care professionals
The course will be of particular relevance to those in the pharmaceutical industry, researchers in the field of respiratory medicine, and specialised clinicians and health care professionals
Información e inscripción:
Ms. Karina Dixon
Investigación clínica, Medicina Intensiva, Medicina interna
Idioma
Inglés
Inglés
Costos
GBP 650,00
GBP 650,00
Cantacto organizador
Dovehouse Street
SW3 6LY London
United Kingdom
Dovehouse Street
SW3 6LY London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
